Jefferies Financial Group Inc. Axonics, Inc. Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$49.38 - $63.75 $14.2 Million - $18.3 Million	-286,856 Reduced 98.55%	4,210 $261,000
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $35,409 - $45,507	-728 Reduced 0.25%	291,066 $16.3 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $14 Million - $17.5 Million	290,745 Added 27716.4%	291,794 $14.7 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $55,177 - $70,639	1,049 New	1,049 $57,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.